CTSB and neoplasm: Subsequently a tumor-specific enzyme cathepsin B is anticipated to mediate the nanoconversion of (Ac)FRRF-DTX NPs into the active PTXm (3), which inhibits microtubule formation and thereby induces selective cytotoxicity (Fig. 1c).